Blinded by the promise of quick money, the potential for a magic solution and you're right, a lack of understanding of the types and phases of clinical trials.
It's a phase 2a trial which ran for 6 weeks, with a 36 week phase 2b planned.
Xanamem has had it's safety profile strengthened further by this trial, with lasting beneficial effects which bodes well for phase 2b.
Ann: ACW XanaCIDD phase 2a trial topline results, page-50
-
- There are more pages in this discussion • 81 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
